Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Mitsubishi Tanabe files for approval of tenegliptin in Japan

Sep. 1, 2011

British company patents novel neuropeptide Y2 receptor ligands

Sep. 1, 2011

Johnson & Johnson presents potential novel approach to treat diabetes and obesity

Sep. 1, 2011

Tianjin Institute of Pharmaceutical Research discloses new agents for diabetes

Sep. 1, 2011

Bionovo reports data from Menerba trial in postmenopausal women

Aug. 31, 2011

Aeterna Zentaris reports encouraging phase III data on AEZS-130

Aug. 31, 2011

Preclinical program of afamelanotide for erythropoietic protoporphyria completed

Aug. 31, 2011

Chinese institute presents novel sodium/glucose cotransporter 2 inhibitors

Aug. 31, 2011

Takeda initiates two phase II trials of TAK-385 in Japan

Aug. 29, 2011

Phase III trial compares Ferinject and Venofer in IBD-associated iron deficiency anemia

Aug. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...